Výsledky vyhledávání - "Oleg Budanov"

Akademický článek

Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL

Autor: Guenter Henze, Ekaterina Mikhailova, Alexander Popov, Julia Roumiantseva, Oleg Budanov, Svetlana Lagoyko, Liudmila Zharikova, Natalia Miakova, Dmitry Litvinov, Lili Khachatryan, Alexey Pshonkin, Natalia Ponomareva, Elmira Boichenko, Svetlana Varfolomeeva, Julia Dinikina, Galina Novichkova, Alexander Karachunskiy

Publikováno v: Journal for ImmunoTherapy of Cancer, Vol 12, Iss 6 (2024)

The bispecific T cell-binding antibody blinatumomab (CD19/CD3) is widely and successfully used for the treatment of children with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Here, we report the efficacy of a single

Externí odkaz: https://doaj.org/article/df13223cf72b4f50af1be617fa311e73

Zobrazit plný text záznamu

Akademický článek

Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non‐high‐risk acute lymphoblastic leukemia treated according to the ALL‐MB 2008 protocol

Publikováno v: Cancer Medicine, Vol 13, Iss 8, Pp n/a-n/a (2024)

Abstract Background Quantitative measurement of minimal residual disease (MRD) is the “gold standard” for estimating the response to therapy in childhood B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL). Nevertheless, the speed of the

Externí odkaz: https://doaj.org/article/c4c2656517d94dbf8dad00592e9fda64

Zobrazit plný text záznamu

Plný text ve formátu HTML

A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement

Publikováno v: Pediatric Blood & Cancer. 70

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6095dde2b681002a1051a9c2163675d0
https://doi.org/10.1002/pbc.30295

Zobrazit plný text záznamu

Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008

Autor: Alexander Popov, Guenter Henze, Julia Roumiantseva, Oleg Budanov, Tatiana Verzhbitskaya, Elena Boyakova, Grigory Tsaur, Maria Fadeeva, Svetlana Lagoyko, Liudmila Zharikova, Natalia Miakova, Dmitry Litvinov, Olga Khlebnikova, Olga Streneva, Natalia Ponomareva, Galina Novichkova, Larisa Fechina, Alexander Karachunskiy

Publikováno v: Leukemia research. 125

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d035c361a71bf8457b5f1d108f942d9f
https://pubmed.ncbi.nlm.nih.gov/36566537

Zobrazit plný text záznamu

One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study

Publikováno v: Journal of cancer research and clinical oncology.

Measurement of minimal residual disease (MRD) with multicolor flow cytometry (MFC) has become an important tool in childhood acute lymphoblastic leukemia (ALL), mainly to identify rapid responders and reduce their therapy intensity. Protocols of the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39556403cdd590f3bdcc9423f065744e
https://pubmed.ncbi.nlm.nih.gov/36169717

Zobrazit plný text záznamu

A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008

Publikováno v: Leukemia research. 123

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85439bb29d635838b1037bf8c2b48660
https://pubmed.ncbi.nlm.nih.gov/36332292

Zobrazit plný text záznamu

A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results

Publikováno v: Leukemia. 36(5)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ec418e9709e613968f8cc0434141504
https://pubmed.ncbi.nlm.nih.gov/35322171

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání